CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Checkmate Pharmaceuticals, Inc. (NasdaqGM:...
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Checkmate Pharmaceuticals, Inc. (NasdaqGM:...
USA News Group – Prior to the recent takeover bid of Twitter Inc. (NYSE:TWTR), by the world’s wealthiest man, Elon Musk, the term “poison pill” was rarely uttered in the market. A quick glance...
Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.
Checkpoint Pharmaceuticals lands a premium-rich buyout offer from biotech heavyweight Regeneron.
Former ARQQ employees are calling out the company today
Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) to Regeneron Pharmaceuticals, Inc. for $10.50 per share in cash is fair...